SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Orchid Pharma receives ANDA approval for Aripiprazole Orally-Disintegrating Tablets

13 Dec 2017 Evaluate

Orchid Pharma has received ANDA approval from USFDA for Aripiprazole Orally-Disintegrating Tablets USP, 10 mg and 15 mg. Aripiprazole Orally-Disintegrating Tablets are atypical antipsychotic, indicated in the treatment symptoms of psychotic conditions such as schizophrenia and bipolar disorder (manic depression).

Orchid Pharma is a pharmaceutical company engaged in development and manufacture of active pharmaceutical ingredients and finished dosage forms. It is also engaged in research of new drugs.


Orchid Pharma Share Price

565.50 -0.10 (-0.02%)
24-Apr-2026 09:39 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1649.75
Dr. Reddys Lab 1325.50
Cipla 1289.55
Zydus Lifesciences 935.60
Lupin 2324.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×